Theriva Biologics Inc (TOVX)
0.4025
-0.02
(-4.17%)
USD |
NYAM |
Apr 30, 16:00
0.393
-0.01
(-2.36%)
Pre-Market: 20:00
Theriva Biologics Free Cash Flow: -19.20M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.20M |
| September 30, 2023 | -18.06M |
| June 30, 2023 | -19.44M |
| March 31, 2023 | -19.91M |
| December 31, 2022 | -19.20M |
| September 30, 2022 | -18.55M |
| June 30, 2022 | -16.24M |
| March 31, 2022 | -14.46M |
| December 31, 2021 | -12.90M |
| September 30, 2021 | -11.23M |
| June 30, 2021 | -11.13M |
| March 31, 2021 | -10.56M |
| December 31, 2020 | -12.18M |
| September 30, 2020 | -12.64M |
| June 30, 2020 | -13.65M |
| March 31, 2020 | -14.61M |
| December 31, 2019 | -13.87M |
| September 30, 2019 | -13.56M |
| June 30, 2019 | -14.10M |
| March 31, 2019 | -15.42M |
| December 31, 2018 | -17.28M |
| September 30, 2018 | -17.92M |
| June 30, 2018 | -19.04M |
| March 31, 2018 | -20.48M |
| December 31, 2017 | -20.42M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.24M |
| June 30, 2017 | -28.65M |
| March 31, 2017 | -28.77M |
| December 31, 2016 | -28.47M |
| September 30, 2016 | -28.73M |
| June 30, 2016 | -38.20M |
| March 31, 2016 | -39.63M |
| December 31, 2015 | -39.39M |
| September 30, 2015 | -33.16M |
| June 30, 2015 | -22.11M |
| March 31, 2015 | -18.13M |
| December 31, 2014 | -16.13M |
| September 30, 2014 | -14.06M |
| June 30, 2014 | -11.23M |
| March 31, 2014 | -9.564M |
| December 31, 2013 | -7.755M |
| September 30, 2013 | -9.816M |
| June 30, 2013 | -9.533M |
| March 31, 2013 | -9.176M |
| December 31, 2012 | -8.926M |
| September 30, 2012 | -4.881M |
| June 30, 2012 | -4.343M |
| March 31, 2012 | -4.009M |
| December 31, 2011 | -2.875M |
| September 30, 2011 | -2.819M |
Free Cash Flow Range, Past 5 Years
-19.91M
Minimum
Mar 2023
-10.56M
Maximum
Mar 2021
-15.03M
Average
-14.10M
Median
Jun 2019
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Oragenics Inc | -7.291M |
| Nanoviricides Inc | -6.203M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.541M |
| Cash from Investing (Quarterly) | -0.056M |
| Cash from Financing (Quarterly) | -1.457M |
| Free Cash Flow Per Share (Quarterly) | -0.3864 |
| Free Cash Flow Yield | -296.2% |